
Stroke Support Organisation Faculty Tool: Module 4 Launched
Brussels, 31st August 2018 - The eLearning Module 4 of the Stroke Support Organisation Faculty Tool (SSOFT) is published today at the following address www.ssoft.info. In Module 4, using a combination of theory and practice, SSOFT demonstrates the impact of the...

SAFE joined European Brain Council’s call for “Horizon Europe” budget increase
The original information provided at Braincouncil.eu In July this year, European Brain Council launched a statement “Counting down to zero: Towards a future with underfunded health research?” which calls on the European Commission, the European Parliament and the...

SWIFT Direct: Investigating the emergency treatment of patients with an acute ischaemic stroke
Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke (SWIFT DIRECT) Background The SWIFT DIRECT trial investigates the emergency treatment of patients with an...

SWITCH Trial: The treatment of patients with spontaneous bleeding in the brain
Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral hemorrhage (SWITCH): a randomized controlled trial Background The SWITCH trial investigates the treatment of patients with spontaneous intracerebral...

ELAN Study: Should anticoagulants be initiated early or with a certain time delay after a stroke?
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN) started with the recruitment in October 2017 with currently approximately 80 sites in Switzerland and European countries. This pragmatic...